MECOM and acute myeloid leukemia: FISH analysis of interphase nuclei and metaphases to screen for KMT2A and MECOM gene rearrangements is recommended for all diagnostic AML samples if no other entity defining cytogenetic or molecular genetic abnormality is present, as these abnormalities may be cryptic and have a pronounced prognostic impact.